Impact of needle number on dosimetric parameters in high-dose-rate prostate brachytherapy: A single-institution retrospective study
Department of Radiation Oncology, Acibadem City Clinic Mladost, Sofia, Bulgaria
J Contemp Brachytherapy 2026
Data publikacji online: 2026/09/22
- Mendez LC, Morton GC. High dose-rate brachytherapy in the treatment of prostate cancer. Transl Androl Urol 2018; 7: 357-370.
- Strouthos I, Tselis N, Chatzikonstantinou G et al. High-dose-rate brachytherapy for prostate cancer: rationale, current applications and clinical outcome. Cancer Rep (Hoboken) 2022; 5: e1583.
- Henry A, Pieters BR, André Siebert F, Hoskin P; UROGEC group of GEC ESTRO. GEC-ESTRO ACROP prostate brachytherapy guidelines. Radiother Oncol 2022; 167: 244-251.
- Yamada Y, Rogers L, Demanes DJ et al. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 2012; 11: 20-32.
- White EC, Kamrava MR, DeMarco J et al. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry. Int J Radiat Oncol Biol Phys 2013; 85: 543-548.
- Fröhlich G, Agoston P, Lövey J et al. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer. Strahlenther Onkol 2010; 186: 388-395.
- Csányi G, Mayer Á, Hideghyéty K et al. Optimization of the number of catheters in prostate HDR brachytherapy. Pathol Oncol Res 2011; 17: 285-290.
- Chicheł A, Kanikowski M, Skowronek J et al. Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high-dose-rate brachytherapy (HDR-BT) as a boost. J Contemp Brachytherapy 2009; 1: 11-17.
- Chicheł A, Kanikowski M, Skowronek J. Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer. J Contemp Brachytherapy 2009; 1: 145-150.
- Batchelar DL, Chung HT, Loblaw A et al. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for HDR brachytherapy for prostate cancer. Brachytherapy 2016; 15: 399-405.
- Safigholi H, Han DY, Song WY et al. Update of the CLRP Monte Carlo TG-43 parameter database for high-energy brachytherapy sources. Med Phys 2023; 50: 1928-1941.
- Chicheł A, Kanikowski M, Skowronek J. The influence of the number of needles on the prostate HDR treatment plan quality. J Contemp Brachytherapy 2009; 1: 188.
- Frank CH, Ramesh P, Lyu Q et al. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection. Med Phys 2023; 50: 6525-6534.
- Jawad MS, Rhee JG, Yamada Y. Advances in HDR prostate brachytherapy planning and optimization. Semin Radiat Oncol 2023; 33: 55-63.
- Olsën JS, Estefan D, Johansson B et al. Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer. J Contemp Brachytherapy 2022; 14: 7-14.
- Akimoto T, Katoh H, Noda SE et al. Acute genitourinary toxicity after high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2005; 62: 737-744.
- Lu DJ, Kamrava M, Sandler H et al. A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy. Brachytherapy 2020; 19: 216-221.
- Meftahi M, Qiu RLJ, Patel P et al. A novel direction modulated brachytherapy technique for urethra sparing in HDR brachytherapy of prostate cancer. Radiother Oncol 2023; 186: 109801.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
